All-cause mortality in patients with diabetes under glucagon-like peptide-1 agonists: A population-based, open cohort study

Jun-17

AUTHORS : Dr Krishnarajah Nirantharakumar, IOEM Building, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK – Email: K.Nirantharan@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/applied-health/nirantharakumar-krishnarajah.aspx

JOURNAL : Diabetes & Metabolism

REFERENCE: 43(3):211-216

DOI : 10.1016/j.diabet.2017.02.003

All-cause mortality in patients with diabetes under glucagon-like peptide-1 agonists: A population-based, open cohort study

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study